Covid-19 Update

+44 (0)1482 631606

Company News, Covid-19, Infection Control, Product News

New distribution agreement with Novaerus

H&R Healthcare have recently become the new distributors of the exciting Novaerus product range.

Novaerus is part of WellAir, an Irish company on a mission to reduce indoor airborne pollutants to create living, working, and healing spaces that foster rather than detract from human health, productivity and wellbeing. Novaerus technology has been shown to safely and effectively reduce bacteria, viruses, VOCs, and particulate matter in dozens of independent laboratory tests.

Novaerus technology has been independently tested against MS2 Bacteriophage, a commonly used surrogate for SARS-CoV (Coronavirus). This technology was shown to reduce the virus by 99.99%.

We look forward to developing our relationship with Novaerus.